Sign up for the QMED & MD+DI Daily newsletter.
Medtronic Stent's Safety Claims Take a Hit
Medtronic has been trying to get regulators and clinicians to believe that its drug-eluting stent, Endeavor, should be approved and used over existing products because it is safer. However, clinical data revealed Friday throw a wrench into the claim, Bloomberg News reports. Those data show Endeavor to be more associated with blood clots than Boston Scientific's Taxus.
October 8, 2007
1 Min Read
.svg?width=850&auto=webp&quality=95&format=jpg&disable=upscale "Medtronic Stent's Safety Claims Take a Hit")
(However, this did not translate into deaths and heart attacks, which were lower for Endeavor patients than Taxus ones.)This is not the best time for such news. Endeavor will be discussed by an FDA advisory panel on Wednesday, after which the panel will decide whether to recommend it for approval. Even if Endeavor does get through FDA, the new data gives Boston Scientific marketing ammunition.
You May Also Like
